Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 AND paloma-3 clinical trials
Finn, R., et al. Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 AND paloma-3 clinical trials. Breast Cancer Research and Treatment. 2020 AUG 11; https://doi.org/10.1007/s10549-020-05782-4